PEER REVIEW INSTITUTE LAUNCHES NEW SERVICE

Now Providing Independent, Expert Support Addressing the Unique Needs of Boards of Directors

Blue Bell, PA September 30, 2014 □ Peer Review Institute (PRI) announced today that it is expanding its services to provide support for members of Boards of Directors in the pharmaceutical, biotech, and medical device industries. Board members are legally accountable and often faced with the challenge of assessing management proposals without the benefit of a staff or relevant information to support their assumptions or evaluations. Peer Review Institute offers board members an independent perspective from consultants with industry expertise across numerous functional areas to assist in their vetting and validation process.

Peer Review Institute maintains a roster of over 350 consultants who have extensive industry experience in many specialty areas including medical affairs, clinical research and development, health economics, regulatory affairs, legal, finance, forecasting, and commercial operations.

“With an advisory team comprised of accomplished, senior-level experts in the healthcare industry, we are able to support board members in their review of diverse projects such as strategic planning, mergers and acquisitions, budgeting, forecasting, and in pressure testing assumptions that guide prioritization of company projects,” stated Albert Wertheimer, Ph.D., Principal and co-founder of Peer Review Institute.

About Peer Review Institute:

PRI provides expert consulting support for the pharmaceutical, biotech, and medical device industries. In addition to supporting Boards of Directors, it offers a broad range of services including support for regulatory filings, dossier preparation, advisory services, and the professional vetting of promotional material to help ensure that product claims are clinically sound, fair-balanced, and compatible with current scientific literature.

For more information, please visit www.PeerReviewInstitute.com

Contact:

Peter L. Tobar

Vice President, Business Development

peter@peerreviewinstitute.com

484.318.7532

###

BOD Press Release

PEER REVIEW INSTITUTE ANNOUNCES EXPANSION OF SERVICES

Now Providing Expert, Outsourced Medical, Regulatory and Legal Talent

Blue Bell, PA March 4, 2013 □ Peer Review Institute (PRI) today announced that it is expanding its services to include the sourcing of contract Medical, Regulatory and Legal personnel to facilitate the internal review of promotional materials for the pharmaceutical and medical device industries.

The workload for promotional review committees is typically very heavy and can often be made even more challenging by vacancies or product launches. This demanding workload can be critical in light of the FDA’s Office of Prescription Drug Promotion (OPDP) rigorous enforcement of prescription drug information to ensure that it is truthful, balanced and accurately communicated. PRI’s new service offers companies access to highly experienced individuals who can handle any or all aspects of the promotional review process to help ensure conformance with OPDP guidelines. For smaller companies, this service could enable the complete outsourcing of the promotional review function, while moderate to large companies may look to this service to fill specific personnel coverage gaps for shorter periods.

“Peer Review Institute has an advisory team comprised of accomplished, senior level experts in the healthcare industry, many of whom have extensive experience working both in industry and at FDA. Additionally, with nearly 300 medical reviewers on-board, we can provide clients access to clinicians who have deep expertise in virtually every facet of medical specialization,” says Albert Wertheimer, Ph.D., Principal and co-founder of Peer Review Institute.

In a statement, Peter Tobar, Vice President, Business Development said, “The outsourcing of critical functions has become widely adopted within the pharmaceutical industry as evidenced by the growth of contract sales organizations (CSO’s) and contract research organizations (CRO’s). Our service provides a new and economical alternative for staffing review committees, with the added flexibility of taking on short or longer term assignments.”

About Peer Review Institute: Peer Review Institute was established to support the pharmaceutical, biotech and medical device industries by enhancing the credibility and regulatory compliance of their promotional messaging. In addition to providing outsourced, contract Medical, Regulatory and Legal reviewers, PRI also offers its clients a professional vetting of their promotional material by independent, therapeutic category experts to help ensure that product claims are clinically sound, fair-balanced, and compatible with the current scientific literature. http://www.peerreviewinstitute.com/

Press Release CPRC Final

PEER REVIEW INSTITUTE AND TOBAR, LLC ANNOUNCE STRATEGIC PARTNERSHIP

A Collaboration to Enhance the Credibility and Compliance of Pharmaceutical Promotion

Blue Bell, PA October 17, 2011 □ Peer Review Institute (PRI) and TOBAR, LLC today announced a strategic partnership that will expand the adoption of PRI services among pharmaceutical, biotech and medical device manufacturers. Regulatory agencies, physicians, and scientific journals have increasingly expressed concern regarding the accuracy and objectivity of manufacturer-initiated information. PRI offers clients an independent review of their promotional initiatives to ensure that all claims are scientifically validated.

“Peer Review Institute has a highly distinguished Board of Advisors and access to hundreds of physicians and pharmacists who are expert in virtually every area of medical specialization. Through our new partnership with TOBAR, LLC, an increasing number of customers will have access to our independent experts, who in turn will provide objective and balanced vetting of promotional materials,” says Albert Wertheimer, Ph.D., Principal and co-founder of Peer Review Institute.

In a statement, Peter Tobar, Principal at TOBAR, LLC said, “Peer Review Institute offers drug manufacturers an outstanding resource to ensure that their promotion remains consistent with the goals of FDA’s Division of Drug Marketing, Advertising and Communication (DDMAC) in protecting public health. Specifically, they help assure that prescription drug information is truthful, balanced and accurately communicated.”

About Peer Review Institute: Peer Review Institute was established to support the pharmaceutical, biotech and medical device industries by enhancing the credibility and regulatory compliance of their promotional messaging. PRI offers clients a professional vetting of their promotional material by independent, therapeutic category experts to help ensure that product claims are clinically sound, fair-balanced, and compatible with the current scientific literature. http://www.peerreviewinstitute.com/

About TOBAR, LLC: TOBAR LLC was established in January 2010 by Peter Tobar as a consulting company providing marketing support within the pharmaceutical and vaccines industry. Mr. Tobar, who serves as managing partner of TOBAR, LLC has broad leadership experience in marketing and sales management having worked 20 years for Wyeth Pharmaceuticals (acquired by Pfizer, Inc). He is widely known in the industry for leading the marketing team that launched Prevnar, the most commercially successful worldwide introduction of a vaccine.

Contact:

Peer Review Institute
P.O. Box 1386
Blue Bell, PA 19422-1386 610-888-4385 Jackie@peerreviewinstitute.com

TOBAR, LLC
1286 Farm Road Berwyn, PA 19312 484.318.7532 peter.tobar@comcast.net

Press Release PRI